We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+11.12%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$58.8B
AUM Growth
+$6.86B
Cap. Flow
+$1.53B
Cap. Flow %
2.61%
Top 10 Hldgs %
38.38%
Holding
782
New
81
Increased
247
Reduced
392
Closed
51

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$284M
2
BABA icon
Alibaba
BABA
+$180M
3
AMZN icon
Amazon
AMZN
+$179M
4
META icon
Meta Platforms (Facebook)
META
+$140M
5
SLB icon
SLB Ltd
SLB
+$139M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Consumer Discretionary 17.2%
3 Healthcare 13.55%
4 Communication Services 11.97%
5 Financials 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$219B
$839M 1.43%
3,479,975
+114,809
+3% +$25.3M
SLB icon
27
SLB Ltd
SLB
$76.5B
$793M 1.35%
19,730,634
+3,892,503
+25% +$139M
CL icon
28
Colgate-Palmolive
CL
$74.1B
$777M 1.32%
11,286,968
+441,957
+4% +$30.1M
FDS icon
29
Factset
FDS
$9.77B
$760M 1.29%
2,833,172
+87,437
+3% +$22.5M
YUM icon
30
Yum! Brands
YUM
$41.6B
$757M 1.29%
7,519,848
+289,290
+4% +$30M
YUMC icon
31
Yum China
YUMC
$16.5B
$727M 1.24%
15,150,125
+308,479
+2% +$13.7M
MRK icon
32
Merck
MRK
$317B
$536M 0.91%
6,173,527
+213,241
+4% +$17.5M
VAR
33
DELISTED
Varian Medical Systems, Inc.
VAR
$467M 0.79%
3,285,359
-1,283,980
-28% -$164M
ADP icon
34
Automatic Data Processing
ADP
$109B
$445M 0.76%
2,607,844
+68,242
+3% +$11.3M
GLW icon
35
Corning
GLW
$135B
$306M 0.52%
10,496,135
-91,118
-0.9% -$2.64M
UNH icon
36
UnitedHealth
UNH
$367B
$257M 0.44%
874,105
+267,787
+44% +$70.1M
ROP icon
37
Roper Technologies
ROP
$39.3B
$257M 0.44%
724,442
+233,622
+48% +$80.7M
DHR icon
38
Danaher
DHR
$141B
$253M 0.43%
1,862,373
+431,891
+30% +$54.6M
MAR icon
39
Marriott International
MAR
$93.8B
$237M 0.4%
1,563,234
+502,124
+47% +$67.3M
F icon
40
Ford
F
$55B
$230M 0.39%
24,708,495
-444,453
-2% -$4M
SHW icon
41
Sherwin-Williams
SHW
$88.2B
$213M 0.36%
1,093,116
+290,289
+36% +$55.4M
CBRE icon
42
CBRE Group
CBRE
$42.7B
$196M 0.33%
3,203,177
+1,129,347
+54% +$62.5M
IQV icon
43
IQVIA
IQV
$38.3B
$186M 0.32%
1,204,775
+802,050
+199% +$117M
ACN icon
44
Accenture
ACN
$105B
$176M 0.3%
836,848
+247,235
+42% +$48.2M
SPGI icon
45
S&P Global
SPGI
$119B
$165M 0.28%
604,006
+226,081
+60% +$58.7M
LIN icon
46
Linde
LIN
$226B
$160M 0.27%
749,822
+287,367
+62% +$57.9M
UAA icon
47
Under Armour
UAA
$2.73B
$154M 0.26%
7,130,921
+6,186
+0.1% +$120K
BDX icon
48
Becton Dickinson
BDX
$48.8B
$137M 0.23%
517,506
+517,062
+116,455% +$129M
MTD icon
49
Mettler-Toledo International
MTD
$28.5B
$137M 0.23%
172,478
+52,295
+44% +$37.8M
EL icon
50
Estee Lauder
EL
$30.9B
$134M 0.23%
648,447
+647,632
+79,464% +$126M

Similar funds

Loomis, Sayles & Company's Q4 2019 Portfolio in Review

As of Q4 2019, Loomis, Sayles & Company held 782 positions worth $58.8B, up 13% from $52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Loomis, Sayles & Company's Q4 2019 filing shows 81 new, 247 increased, 392 reduced and 51 closed positions. Its largest new stake was Invesco Senior Loan ETF: 2,182,910 shares worth $49.8M. The largest sale was American Express, an estimated $375M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Loomis, Sayles & Company's largest Q4 2019 buy was Invesco Senior Loan ETF: 2,182,910 shares worth $49.8M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2019, an estimated $284M increase.
  • Loomis, Sayles & Company's biggest Q4 2019 reduction was American Express, cutting an estimated $375M.
  • Loomis, Sayles & Company fully exited Grand Canyon Education in Q4 2019, selling an estimated $61M.
  • Loomis, Sayles & Company's ten largest holdings make up 38% of its $58.8B portfolio in Q4 2019.
  • Loomis, Sayles & Company opened 81 new positions and closed 51 in Q4 2019.
  • Loomis, Sayles & Company's portfolio value rose 13% quarter-over-quarter to $58.8B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2019, filed 14 Feb 2020.